BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 16550383)

  • 21. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer's disease.
    Ishii K; Soma T; Kono AK; Sofue K; Miyamoto N; Yoshikawa T; Mori E; Murase K
    J Nucl Med; 2007 May; 48(5):704-11. PubMed ID: 17475957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
    Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K
    J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Inui Y; Toyama H; Manabe Y; Sarai M; Iwata N
    Ann Nucl Med; 2014 Oct; 28(8):796-804. PubMed ID: 24986482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease.
    Testa C; Laakso MP; Sabattoli F; Rossi R; Beltramello A; Soininen H; Frisoni GB
    J Magn Reson Imaging; 2004 Mar; 19(3):274-82. PubMed ID: 14994294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
    Yun HJ; Kwak K; Lee JM;
    PLoS One; 2015; 10(6):e0129250. PubMed ID: 26061669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Support vector machine-based classification of neuroimages in Alzheimer's disease: direct comparison of FDG-PET, rCBF-SPECT and MRI data acquired from the same individuals.
    Ferreira LK; Rondina JM; Kubo R; Ono CR; Leite CC; Smid J; Bottino C; Nitrini R; Busatto GF; Duran FL; Buchpiguel CA
    Braz J Psychiatry; 2018; 40(2):181-191. PubMed ID: 28977066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computer-assisted system for diagnosis of Alzheimer disease using data base- independent estimation and fluorodeoxyglucose- positron-emission tomography and 3D-stereotactic surface projection.
    Uemura T; Ishii K; Miyamoto N; Yoshikawa T
    AJNR Am J Neuroradiol; 2011 Mar; 32(3):556-9. PubMed ID: 21292796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid scanning protocol for brain (18)F-FDG PET: a validation study.
    Chen WP; Matsunari I; Noda A; Yanase D; Yajima K; Takeda N; Yamada M; Minoshima S; Nishimura S
    J Nucl Med; 2005 Oct; 46(10):1633-41. PubMed ID: 16204713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a New Imaging Technique Using the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of Alzheimer's Disease.
    Takahashi R; Ishii K; Yokoyama K; For The Alzheimer S Disease Neuroimaging Initiative EY
    Curr Alzheimer Res; 2017; 14(2):161-168. PubMed ID: 27334941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct comparison study between FDG-PET and IMP-SPECT for diagnosing Alzheimer's disease using 3D-SSP analysis in the same patients.
    Nihashi T; Yatsuya H; Hayasaka K; Kato R; Kawatsu S; Arahata Y; Iwai K; Takeda A; Washimi Y; Yoshimura K; Mizuno K; Kato T; Naganawa S; Ito K
    Radiat Med; 2007 Jul; 25(6):255-62. PubMed ID: 17634878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.
    Chételat G; Desgranges B; Landeau B; Mézenge F; Poline JB; de la Sayette V; Viader F; Eustache F; Baron JC
    Brain; 2008 Jan; 131(Pt 1):60-71. PubMed ID: 18063588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
    Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
    Castellano CA; Nugent S; Paquet N; Tremblay S; Bocti C; Lacombe G; Imbeault H; Turcotte É; Fulop T; Cunnane SC
    J Alzheimers Dis; 2015; 43(4):1343-53. PubMed ID: 25147107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.
    Verclytte S; Lopes R; Lenfant P; Rollin A; Semah F; Leclerc X; Pasquier F; Delmaire C
    J Neuroimaging; 2016; 26(2):207-12. PubMed ID: 26031943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images.
    Ishii K; Kawachi T; Sasaki H; Kono AK; Fukuda T; Kojima Y; Mori E
    AJNR Am J Neuroradiol; 2005 Feb; 26(2):333-40. PubMed ID: 15709131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data.
    Sörensen A; Blazhenets G; Rücker G; Schiller F; Meyer PT; Frings L;
    Neuroimage Clin; 2019; 21():101637. PubMed ID: 30553760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.